{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:03:33Z","timestamp":1789941813500,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijantimicag.2017.08.020","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T06:16:03Z","timestamp":1503555363000},"page":"77-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model"],"prefix":"10.1016","volume":"51","author":[{"given":"Sooraj","family":"Baijnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chivonne","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongani","family":"Ngcobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanil D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik G.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per I.","family":"Arvidsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thavendran","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0010","series-title":"Global tuberculosis control: WHO report 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0015","series-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00042-07","article-title":"Central nervous system tuberculosis: pathogenesis and clinical aspects","volume":"21","author":"Rock","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0025","series-title":"Chemotherapy of leprosy for control programmes: report of a WHO Study Group","author":"World Health Organization","year":"1982"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0030","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1469-0691.2011.03716.x","article-title":"Clofazimine in the treatment of multidrug-resistant tuberculosis","volume":"18","author":"Xu","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0035","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.4081\/idr.2016.6569","article-title":"New antituberculosis drugs: from clinical trial to programmatic use","volume":"8","author":"Gualano","year":"2016","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1416951112","article-title":"Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis","volume":"112","author":"Tyagi","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0045","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis","volume":"59","author":"Swanson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0050","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/AAC.00177-16","article-title":"Clofazimine contributes sustained antimicrobial activity after treatment cessation in a mouse model of tuberculosis chemotherapy","volume":"60","author":"Swanson","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: the first oxazolidinone antimicrobial","volume":"138","author":"Moellering","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0060","doi-asserted-by":"crossref","first-page":"iv7","DOI":"10.1093\/jac\/dkr072","article-title":"Linezolid pharmacokinetics and pharmacodynamics in clinical treatment","volume":"66","author":"Dryden","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0065","first-page":"87","article-title":"Clinical update on linezolid in the treatment of Gram-positive bacterial infections","volume":"5","author":"Ager","year":"2012","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10735-016-9685-0","article-title":"Neuroprotective potential of linezolid: a quantitative and distribution study","volume":"47","author":"Baijnath","year":"2016","journal-title":"J Mol Histol"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10735-015-9634-3","article-title":"Evidence for the presence of clofazimine and its distribution in the healthy mouse brain","volume":"46","author":"Baijnath","year":"2015","journal-title":"J Mol Histol"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/dkw417","article-title":"Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo","volume":"72","author":"Ammerman","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10735-016-9658-3","article-title":"Small molecule distribution in rat lung: a comparison of various cryoprotectants as inflation media and their applicability to MSI","volume":"47","author":"Baijnath","year":"2016","journal-title":"J Mol Histol"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acsinfecdis.6b00051","article-title":"Prediction of drug penetration in tuberculosis lesions","volume":"2","author":"Sarathy","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.08.020_bib0100","doi-asserted-by":"crossref","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","article-title":"PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis","volume":"6","author":"Coleman","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T06:25:08Z","timestamp":1535437508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917303126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0924857917303126"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}